21028 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof; Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
NOVEL METHODS AND MEDICAMENT FOR TREATING INFECTIOUS DISEASES INVOLVING MICROBIAL BIOFILMS
#1802Formulation and Method for the Prevention and Treatment of Skeletal Manifestation of Gaucher's Disease
#1803Dry treatment mixture and methods of production and use
#1804HYALURONIDASE AS AN ADJUVANT FOR INCREASING THE INJECTION VOLUME AND DISPERSION OF LARGE DIAMETER SYNTHETIC MEMBRANE VESICLES CONTAINING A THERAPEUTIC AGENT
#1805Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
#1806SUBCUTANEOUS ADMINISTRATION OF ALPHA-GALACTOSIDASE A
#1807Proteins having acquired A-galactosidase activity
#1808Cosmetic treatment system and methods
#1809Methods of treating coagulopathy
#1810Compositions for inhibiting atherosclerosis
#1811Stable digestive enzyme compositions
#1812Materials and Method for Promotion of Nerve Regeneration
#1813Enzyme delivery systems and methods of preparation and use
#1814Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells
#1815TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE II
#1816Prebiotic oligosaccharides
#1817Drug delivery system for accelerated subcutaneous absorption
#1818COMBINATION ENZYME FOR CYSTIC FIBROSIS
#1819Compositions for promoting wound healing and treating psoriasis
#1820Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
#1821Treatments Which Alleviate Functional Glycosylated Leptin Transport Factor for Controlling Weight and Obesity
#1822USE OF HYDROLYTIC AND OXIDATIVE ENZYMES TO DISSOLVE BIOFILM IN EARS
#1823Method and carrier complexes for delivering molecules to cells
#1824Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
#1825System for obfuscating identity
#1826Controlled release composition comprising a recombinant gelatin
#1827Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
#1828USE OF RAPAMYCIN TO INHIBIT IMMUNE RESPONSE AND INDUCE TOLERANCE TO GENE THERAPY VECTOR AND ENCODED TRANSGENE PRODUCTS
#1829COMPOSITIONS AND METHODS FOR TREATING PANCREATIC INSUFFICIENCY
#1830Myeloid Colony Stimulating Factor and Uses Thereof
#1831Method for screening a test substance for activating a receptor associated with FGF 21 activity
#1832Enzyme replacement therapy for treating lysosomal storage diseases
#1833Gene therapy for lysosomal storage diseases
#1834Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
#1835Hyaluronidase and method of use thereof
#1836System for obfuscating identity
#1837Technology for Preparation of Macromolecular Microspheres
#1838METHOD FOR TREATING RENAL CELL CARCINOMA USING GLYCOGENOLYSIS INHIBITORS
#1839Altered Activity of Toll-Like Receptors
#1840Compositions and methods for enzymatic treatment of lung disorders
#1841Organic Compounds
#1842TREATMENT OF FABRY DISEASE
#1843METHODS OF ENHANCING LYSOSOMAL STORAGE DISEASE THERAPY BY MODULATION OF CELL SURFACE RECEPTOR DENSITY
#1844Use of the endoglycosidase endos for treating immunoglobulin G mediated diseases
#1845Proteolytic enzyme formulations
#1846Human beta-glucuronidase mutants with elevated enzymatic activity under physiological conditions and method for identifying such
#1847STABLE, DURABLE GRANULES WITH ACTIVE AGENTS
#1848THERAPY REGIMENS, DOSING REGIMENS AND STABLE MEDICAMENTS FOR THE TREATMENT OF POMPE DISEASE
#1849METHODS AND COMPOSITIONS RELATED TO MODULATING THE EXTRACELLULAR STEM CELL ENVIRONMENT
#1850METHOD FOR THE TREATMENT OF FABRY DISEASE USING PHARMACOLOGICAL CHAPERONES
#1851METHODS AND COMPOSITIONS FOR THE TREATMENT OF VAGINAL DISEASES EMPLOYING PEROXIDE-PRODUCING ENZYMES AND PEROXIDASES
#1852Method Of Complexing A Protein By The Use Of A Dispersed System And Proteins Thereof
#1853Treatment of cancer with glufosfamide in patients not receiving insulin therapy
#1854Methods of treating anemia using recombinant adeno-associated virus virions
#1855Convection enhanced delivery apparatus, method, and application
#1856Use of hyaluronidase for the prevention or treatment of arterial hypertension or cardiac insufficiency
#1857Treatment of Pompe's Disease
#1858METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF PRION DISEASES
#1859Cosmetic Methods And Compositions For Repairing Human Skin
#1860COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AN ENZYME WHICH IS INSOLUBLE IN AN AQUEOUS MEDIUM AS WELL AS ITS USES
#1861Targeted therapeutic proteins
#1862Lipid microparticle growth factor formulations
#1863Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method
#1864Cosmetic use of chitinase-type proteins
#1865Long-lasting absorption of flavonoids
#1866Glycopegylation methods and proteins/peptides produced by the methods
#1867Oligosaccharides comprising an aminooxy group and conjugates thereof
#1868Methods of Use of Eggshell Polypeptides
#1869Compositions and methods for treating lysosomal storage disease
#1870LIPASE-CONTAINING COMPOSITION AND METHODS OF USE THEREOF
#1871Lipase variants for pharmaceutical use
#1872Solubilized protein composition obtained from eggshell membrane
#1873ANTIMETASTATIC EFFECT ON HUMAN CELL DISORDERS
#1874Stable digestive enzyme compositions
#1875Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients
#1876Lys K endolysin is synergistic with lysostaphin against MRSA
#1877Horse feed and treatment methods
#1878Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders
#1879Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof
#1880COMPOSITION FOR PROVIDING A BENEFIT TO A KERATIN-CONTAINING SUBSTRATE
#1881Recombinant Staphylococcal Phage Lysin as an Antibacterial Agent
#1882PROTEIN-CONTAINING SUBSTANCE WITH INCREASED THERMAL STABILITY
#1883Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
#1884ORAL FORMULATIONS FOR ENTERIC DISORDERS AND/OR REHYDRATION
#1885METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF COMPLEX REGIONAL PAIN SYNDROME
#1886Albumin-Free Botulinum Toxin Based Pharmaceutical Compositions Containing a Hyaluronidase and Methods of Use
#1887Methods and compositions for the treatment of symptoms of Williams Syndrome
#1888Salivary substitute
#1889Antimicrobial composition and uses thereof
#1890Method, Composition, and Device, for the Treatment of Amylase Malfunctions / Inactivity in Association with Saccharides (Mainly Polysaccharides) Based Diseases
#1891NOVEL COMPOSITIONS FOR PREVENTION AND TREATMENT OF MASTITIS AND METRITIS
#1892Combination therapy using a soluble hyaluronidase and a bisphosphonate
#1893Therapeutic Peptide Compositions And Methods Of Making And Using Same
#1894Super fast-acting insulin compositions
#1895Lipid Vesicle Composition
#1896Method for identifying individuals having a pervasive development disorder amenable to digestive enzyme therapy
#1897Methods of treating and diagnosing Parkinsons disease and related dysautonomic disorders
#1898Bactericide having selectivity to cariogenic bacterium, and a method for sterilization of cariogenic bacterium
#1899Method for the treatment of the symptoms of drug and alcohol addiction
#1900Use polysaccharides for promotion of enzymatic activity
#1901Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells
#1902Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
#1903Horse feed and methods of treating horses
#1904Use of fructanases in feed of hoofed animals, preferably to prevent diseases
#1905PROCESS FOR CONCENTRATION OF A POLYPEPTIDE
#1906Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells
#1907TREATMENT OF LAMINITIS
#1908Compositions and use thereof for treating symptoms of preeclampsia
#1909Method for detecting infectious parvovirus in pharmaceutical preparations
#1910Simultaneous Delivery of Receptors and/or Co-Receptors for Growth Factor Stability and Activity
#1911ENCAPSULATION SYSTEM
#1912Imaging and Therapeutic Method Using Monocytes
#1913DIGESTIBLE COMPOSITIONS OF INULIN FOR MANAGING BLOOD GLUCOSE LEVELS
#1914Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP)
#1915Production of high mannose proteins in plant culture and therapeutic uses thereof
#1916Methods of treating anemia using recombinant adeno-associated virus virions
#1917TARGETED THERAPEUTIC PROTEINS
#1918INHIBITION AND TREATMENT OF GASTROINTESTINAL BIOFILMS
#1919Composition for Sustained Release Delivery of Proteins or Peptides
#1920Method for identifying autistic individuals amenable to digestive enzyme therapy
#1921AMELIORATING AGENT FOR BRAIN DAMAGE
#1922Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
#1923Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
#1924Method for increasing fructose digestion with strains of and fructase
#1925PDGF fusion proteins incorporated into fibrin foams
#1926Series spring blade tensioner
#1927Compositions for inhibiting atherosclerosis
#1928Anesthetic composition, formulation and method of use
#1929Methods for increasing lactose and fructose digestion
#1930APOLIPOPROTEIN ANALOGUES
#1931Method for treating pervasive development disorders
#1932Intraventricular enzyme delivery for lysosomal storage diseases
#1933Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble Glycosaminoglycanases
#1934Targeting ABCB5 for cancer therapy
#1935METHOD OF DETERMINING VACCINE COMPLIANCE
#1936Process for solubilizing protein from a proteinaceous material and compositions thereof
#1937Technology for the Preparation of Microparticles
#1938Mucopolysaccharidosis (MPS) diagnostic methods, systems, kits and assays associated therewith
#1939AGENT FOR USE IN THE CASE OF FRUCTOSE INTOLERANCE
#1940NON-PANCREATIC PROTEASES FOR CONTROLLING PLASMA CHOLECYSTOKININ (CCK) CONCENTRATION AND FOR TREATING PAIN
#1941Method of treating gaucher disease
#1942Compositions for promoting wound healing and treating psoriasis
#1943Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system
#1944Reconstitution medium for protein and peptide formulations
#1945COSMETIC METHODS AND COMPOSITIONS FOR REPAIRING HUMAN SKIN
#1946SPERM-BLOCKING AGENT COMPOSITION WITH CONTRACEPTIVE EFFECT
#1947CANCER TREATMENT BY METABOLIC MODULATIONS
#1948Method for targeting lysosomal enzymes
#1949Anti-hypertensive functional food products
#1950USE OF ANTIMICROBIAL PROTEINS AND PEPTIDES FOR THE TREATMENT OF OTITIS MEDIA AND PARANASAL SINUSITIS
#1951INJECTABLE, NONAQUEOUS SUSPENSION WITH HIGH CONCENTRATION OF THERAPEUTIC AGENT
#1952Delivery of therapeutic compounds to the brain and other tissues
#1953Natural liniment for treatment of skin cancers
#1954Colonic Delivery of Active Agents
#1955Enteric-Coated Glucosinolates And Beta-Thioglucosidases
#1956Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions
#1957Acid alpha-glucosidase and fragments thereof
#1958Stable digestive enzyme compositions
#1959Composition Comprising Polymeric Material And Uses Thereof
#1960Methods of producing stable pancreatic enzyme compositions
#1961GEL-BASED DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS VECTORS
#1962Composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrosis as well as people suffering from pancreatic lipase insufficiency
#1963Stable pancreatic enzyme compositions
#1964Gene Delivery to Organs
#1965METHODS AND RELATED SYSTEMS AND FORMULATIONS TO NORMALIZE AND IMPROVE HUMAN BODY CHEMISTRY AND HEALING ABILITY
#1966Standardized bee venom preparation
#1967Use of Hyaluronidase in Combination with Plasmin for the Induction of Posterior Vitreous Detachment
#1968Glucanases, nucleic acids encoding them and methods for making and using them
#1969Targeting of glycoprotein therapeutics
#1970Vectors having both isoforms of beta-hexosaminidase and uses of the same
#1971Methods of treating pervasive development disorders
#1972Compositions for treatment of gastro-esophageal reflux disorders
#1973Composition and method for treating bovine papilloma virus in equine
#1974Enzyme containing composition, process of producing said composition and its use
#1975NOVEL OPHTHALMIC COMPOSITIONS CONTAINING HUMAN RECOMBINANT LYSOZYME AND USE THEREOF FOR TREATING EYE CONDITIONS AND AS CONTACT LENS SOLUTIONS
#1976Treatment of Pompe's disease
#1977Recombinant Newcastle Disease Virus
#1978Botulinum toxin compositions and methods
#1979Botulinum toxin compositions and methods
#1980ENZYME COMPOSITION FOR IMPROVING FOOD DIGESTION
#1981Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors
#1982Formulations including digestive enzymes and polysorbate surfactants that enhance the colonization of administered probiotics microoganisms
#1983Treatment of glycogen storage disease type II
#1984COMBINATION ENZYME FOR CYSTIC FIBROSIS
#1985Methods of treating and diagnosing Parkinson's disease and related dysautonomic disorders
#1986Formulations including monovalent alginate to enhance effectiveness of administered digestive enzymes
#1987System for obfuscating identity
#1988USE OF HYALURONIDASE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES
#1989Method of reducing CRF receptor mRNA
#1990Xylanase gene sequences from the genomic DNA of unpurified rumen microorganisms
#1991Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
#1992Sphingolipids' polyalkylamines conjugates
#1993USE OF RAPAMYCIN TO INHIBIT RESPONSE AND INDUCE TOLERANCE TO GENE THERAPY VECTOR AND ENCODED TRANSGENE PRODUCTS
#1994Broad specturm anti-viral therapeutics and prophylaxis
#1995Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors
#1996System for obfuscating identity
#1997System for obfuscating identity
#1998Methods for increasing lactose digestion
#1999Human lysosomal proteins from plant cell culture
#2000HUMAN LYSOZYME MEDICINE, ITS MANUFACTURING METHOD AND APPLICATION THEREOF
#2001METHOD FOR MODULATING THE PHARMACOKINETICS AND METABOLISM OF A THERAPEUTIC AGENT
#2002Compositions and methods for the treatment of CNS injuries
#2003Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers
#2004Pharmaceutical compositions for sustained release delivery of peptides
#2005Nutrient absorption enhancing compositions and methods
#2006METHODS TO PREVENT AND TREAT DISEASES
#2007Formulation of liposomal vesicles in aqueous solutions with lachrymal film characteristics
#2008Novel methods for ester detoxication
#2009Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases
#2010Compositions and methods for the cure of HIV / AIDS
#2011Compositions of less immunogenic and long-circulating protein-lipid complexes
#2012SPHINGOID POLYALKLAMINE CONJUGATES, ISOMERS AND USES THEREOF
#2013Use of Human Lysozyme in Preparation of Medicine for Treating Acne
#2014Methods and compositions for remediation of disc herniation by modifying structure
#2015Cosmetic treatment system and methods
#2016Augmentation of titer for vaccination in animals
#2017Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
#2018Genetic modification of the lung as a portal for gene delivery
#2019Polypeptides and compositions derived from the horny layer of the epidermis and its use
#2020Chondroitinase ABC I and methods of production
#20212-METHYLTHIAZOLIDINE-2, 4-DICARBOXYLIC ACID-CONTAINING COMBINATION PREPARATIONS
#2022Use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses
#2023USE OF ANTIMICROBIAL PROTEINS AND PEPTIDES FOR THE TREATMENT OF OTITIS MEDIA AND PARANASAL SINUSITIS
#2024Chondroitinase ABC I and methods of analyzing therewith
#2025Use of β-1,3 (4)-endoglucanohydrolase, β-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function
#2026Stabilized compositions of proteins having a free thiol moiety
#2027Technology for preparation of macromolecular microspheres
#2028Combination therapy for treating protein deficiency disorders
#2029Partially deglycosylated glucocerebrosidase polypeptide and crystals thereof
#2030Sugar chain-cleaving agent
#2031Chondroitinase ABC I and methods of degrading therewith
#2032Rationally designed heparinases derived from heparinase II
#2033Chondroitinase ABC I polynucleotides
#2034Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof
#2035Delayed release pancreatin compositions
#2036Process for the manufacture and use of pancreatin micropellet cores
#2037Use of cathepsin s inhibitors for treating an immune response caused by administration of a small molecule therapeutic or biologic
#2038Enzymes for reduced immunological stress
#2039Ophthalmic surgical irrigating solutions containing hyaluronidase and method for preventing post-operative intraocular pressure increases
#2040Treatment of ophthalmic conditions
#2041Novel methods and medicament for treating infectious diseases involving microbial biofilms
#2042PHARMACEUTICAL PREPARATIONS FOR ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND OTHER ASSOCIATED DISORDERS
#2043Treatments which Alleviate Functional Glycosylated Leptin Transport Factor, for Controlling Weight and Obesity
#2044USE OF MODIFIED LYSOZYME C TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES
#2045Lysozyme fortified milk and milk products
#2046Composition for the treatment of bad breath
#2047Microfabricated nanopore device for sustained release of therapeutic agent
#2048METHOD OF TREATING AND DIAGNOSING PARKINSONS DISEASE AND RELATED DYSAUTONOMIC DISORDERS
#2049Polysaccharide-functionalized nanoparticle, drug delivery system for controlled release comprising the same and preparation method thereof
#2050High mannose proteins and methods of making high mannose proteins
#2051Compositions and methods for enhancing axon regeneration
#2052Glycopegylation methods and proteins/peptides produced by the methods
#2053Bacteriophage lysins for and other bacteria
#2054COMPOSITIONS FOR PREVENTION AND TREATEMENT OF SYMPTOMS OF GASTROINTESTINAL DISTRESS
#2055Methods and compositions related to modulating the extracellular stem cell environment
#2056Lysosomal proteins produced in the milk of transgenic animals
#2057Composition and system for wound decontamination
#2058Imaging and therapeutic method using monocytes
#2059Substitute for animal protein in cattle feed
#2060Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
#2061Cell and virus catabolism
#2062Method for producing glucoamylases and their uses
#2063Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy
#2064Method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives
#2065Sphingolipids polyalkylamine conjugates for use in transfection
#2066Sphingoid polyalkylamine conjugates for vaccination
#2067Method and apparatus for treatment of cardiac disorders
#2068Myeloid colony stimulating factor and uses thereof
#2069Methods and compositions for the inhibition of growth of infectious and other mycotic organisms in the gut of mammalian and avian species
#2070T. cruzi-derived neurotrophic agents and methods of use therefor
#2071Targeting of glycoprotein therapeutics
#2072Combination enzyme for cystic fibrosis
#2073Combination therapy for controlled carbohydrate digestion
#2074Methods for treating pervasive development disorders
#2075Methods for treating pervasive development disorders
#2076Treatment of α-galactosidase A deficiency
#2077Uses of sysnergistic bacteriophage lytic enzymes for prevention and treatment of bacterial infections
#2078Stable formulations of purified proteins
#2079Lipase-containing composition and methods of use thereof
#2080Controlled release composition
#2081Compositions for treating cystic fibrosis
#2082Compositions and methods for treating pancreatic insufficiency
#2083Combination gene delivery vehicles
#2084Dietary supplement for treating and preventing gastrointestinal disorders
#2085Enzyme containing composition, process of producing said composition and its use
#2086Rationally designed heparinases derived from heparinase I and II and methods of sequencing therewith
#2087Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
#2088Compositions and methods for modifying toxic effects of proteinaceous compounds
#2089Methods of treating anemia using recombinant adeno-associated virus virions
#2090Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors
#2091Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products
#2092Sperm specific lysozyme-like proteins
#2093Methods of intracellular peptide delivery
#2094Hyaluronic acid in the enhancement of lens regeneration
#2095Use of an enzyme for the manufacture of an agent for controlling bacterial infection
#2096Recombinant chondroitinase ABC I and uses thereof
#2097Gel-based delivery of recombinant adeno-associated virus vectors
#2098Topical pathogenic-tissue-destroying liquid
#2099Aminoglycoside treatment for lysosomal storage diseases
#2100Pharmaceutical composition comprising carriers for products